Ocuphire Pharma Investor Day Presentation Deck

RM 71 Practice Implementation Models Positive Feedback from Physicians on Integration of a Reversal Agent into Practice Optometry TON LPED. PECFD EDTCZP FELOPED DEFPOTRO Ophthalmology PO Retina Adoption into practice requires no additional staff or patient training Practices across all specialties expressed the positive impact on patient experience and adherence to dilated exams Physician Interviews Conducted by Ocuphire Ophthalmology and Optometry practices would pass a nominal fee into their routine refraction and include it in their surgical pricing Retina practices across academic centers favored offering to patients at no additional cost due to the volume of dilated exams and as a patient satisfaction service Ocuphire PHARMA

View entire presentation